Subscribe: Lung Cancer News From Medical News Today
http://www.medicalnewstoday.com/rss/lung_cancer.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
cancer  cell lung  cell  chemotherapy  free survival  lung cancer  lung  new  progression free  small cell  small  study  survival  treatment 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Lung Cancer News From Medical News Today

Lung Cancer News From Medical News Today



Lung cancer is one of the most common and serious types of cancer; it can start in the windpipe, the main airway or the lung tissue. Although there are no early signs and symptoms, the condition will eventually develop symptoms such as a persistent cough,



Copyright: Copyright 2016 Medical News Today
 



Is smoking ever safe? Study investigates

Mon, 05 Dec 2016 09:00:00 PST

The harmful effects of smoking are well known, but a new study investigates the health risks associated with a lower level of tobacco use.



Parker Institute for Cancer Immunotherapy and Cancer Research Institute launch collaboration on cancer neoantigens

Thu, 01 Dec 2016 06:00:00 PST

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) announce a major collaboration focused on neoantigens.



Scientists step closer to halting spread of lung cancer

Fri, 25 Nov 2016 06:00:00 PST

Scientists at the Universities of York and Texas have found that a component of cancer cells, which acts like a 'cellular post office', could be the key to preventing the spread of lung cancer to...



Blood test could predict best treatment for lung cancer

Tue, 22 Nov 2016 00:00:00 PST

A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research published in Nature Medicine.



Scientists develop tissue-engineered model of human lung and trachea

Tue, 15 Nov 2016 00:00:00 PST

Scientists at Children's Hospital Los Angeles have developed a tissue-engineered model of lung and trachea which contains the diverse cell types present in the human respiratory tract.



Twenty cigarettes daily for 1 year equals 150 lung cell mutations

Fri, 04 Nov 2016 00:00:00 PST

Although smoking's links with cancer are well known, how tobacco affects DNA in far flung organs was not understood. New analysis digs into the genes.



What proportion of cancer deaths are attributable to smoking around the U.S.?

Tue, 25 Oct 2016 06:00:00 PST

The proportion of cancer deaths attributable to cigarette smoking varied across the United States but was highest in the South, where nearly 40 percent of cancer deaths in men were estimated to be...



Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma

Tue, 25 Oct 2016 00:00:00 PST

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.



Study shows new drug targets may boost protein inhibitor, survival for lung cancer patients

Wed, 19 Oct 2016 06:00:00 PST

Lung cancer is the leading cause of death among both men and women in the United States.



MEK inhibition in KRAS-mutant non-small-cell lung cancer (NSCLC) did not improve survival

Wed, 12 Oct 2016 00:00:00 PST

MEK inhibitor selumetinib in combination with docetaxel does not improve progression free or overall survival in individuals with KRAS-mutant non-small-cell lung cancer (NSCLC), according to data...



Greater patient selection may be needed for first line nivolumab to improve progression-free survival in advanced lung cancer

Tue, 11 Oct 2016 05:00:00 PST

Greater patient selection may be needed for first line nivolumab to improve progression-free survival over chemotherapy in advanced lung cancer as the CheckMate 026 trial gave negative results in a...



Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression

Tue, 11 Oct 2016 05:00:00 PST

Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression, according to the results of the phase III KEYNOTE-024 trial...



First-line pembrolizumab plus chemotherapy significantly improves outcomes in advanced non-small-cell lung cancer

Tue, 11 Oct 2016 00:00:00 PST

The addition of PD-1 antibody pembrolizumab to standard first-line chemotherapy for treatment-naïve advanced non-small-cell lung cancer significantly improves response rates and progression-free...



Significant survival gains with atezolizumab vs docetaxel for non-small-cell lung cancer

Tue, 11 Oct 2016 00:00:00 PST

The first phase III study of PD-L1 inhibitor atezolizumab in previously-treated non-small-cell lung cancer has seen significant improvements in survival compared to standard chemotherapy...



Ceritinib provides longer progression-free survival than chemotherapy in phase III trial of ALK rearranged lung cancer treatment

Tue, 11 Oct 2016 00:00:00 PST

Ceritinib provides longer progression-free survival than chemotherapy in crizotinib-pre-treated patients with non-small-cell lung cancer harbouring an ALK rearrangement, according to results of the...



Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer

Mon, 10 Oct 2016 06:00:00 PST

Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.



Blocking Ran protein reverses resistance of lung and breast cancers

Thu, 06 Oct 2016 00:00:00 PST

Researchers at the University of Bradford have discovered a way to prevent chemotherapy resistance in lung cancer by blocking a protein found in cancer cells.



Blood pressure drug may boost effectiveness of lung cancer treatment

Tue, 27 Sep 2016 05:00:00 PST

A blood pressure drug may make a type of lung cancer treatment more effective, suggests a new study.



Newly discovered immune cell type protects against lung infections during chemotherapy

Mon, 26 Sep 2016 00:00:00 PST

St. Jude Children's Research Hospital investigators have identified a new form of an immune cell that protected mice from life-threatening lung infections under conditions that mimic cancer...



Cancer growth model simulates cell-killing ability of combos

Thu, 22 Sep 2016 11:00:00 PST

New model could improve personalized treatment for people with one subtype of lung cancer.



Whole brain radiotherapy offers little benefit to people whose lung cancer has spread to the brain, despite its widespread use

Mon, 05 Sep 2016 05:00:00 PST

People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet.



Targeting low-oxygen patches inside lung cancer tumors could help prevent drug resistance

Mon, 29 Aug 2016 00:00:00 PST

With the right treatment schedule, medications known as hypoxia-activated prodrugs (HAPs) could help prevent drug resistance in a subtype of lung cancer, according to a study published in PLOS...



Smokers with newly discovered genetic markers have higher lung cancer risk

Fri, 26 Aug 2016 00:00:00 PST

University of Hawai'i Cancer Center researchers discovered new genetic markers associated with a fast rate of nicotine metabolism, which potentially leads smokers to smoke more, thereby...



Study: Smokers who switch to e-cigarettes exposed to same levels of nicotine, lower carcinogen levels

Fri, 19 Aug 2016 05:00:00 PST

A study led by researchers at Roswell Park Cancer Institute (RPCI) reports that nicotine exposure remains the same, while exposure to specific carcinogens and toxicants is reduced, among smokers...



Researchers from CSI Singapore discover new way to inhibit development of lung cancer

Mon, 08 Aug 2016 05:00:00 PST

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), in collaboration with Harvard Stem Cell Institute (HSCI), have discovered a...